Joshua McDonough1, Jaklin Eliott1, Susan Neuhaus2, Jessica Reid2, Phyllis Butow3,4. 1. School of Public Health, University of Adelaide, Adelaide, Australia. 2. Discipline of Surgery, University of Adelaide, Adelaide, Australia. 3. Psycho-Oncology Co-operative Research Group, University of Sydney, Sydney, Australia. 4. School of Psychology, University of Sydney, Sydney, Australia.
Abstract
OBJECTIVE: Health-related quality of life (HRQoL), psychosocial distress, and unmet health needs are important patient-reported outcomes (PROs) for patients with sarcoma treated with curative intent. Syntheses of data on these PROs in patients with sarcoma are limited. METHODS: A systematic review of peer-reviewed literature published between 2007 and 2017 was conducted using five databases, guided by the PRISMA and Cochrane reporting guidelines. RESULTS: Of 7240 articles identified, 31 were included in this review. Compared with healthy individuals, patients with sarcoma frequently scored lower in physical and psychological HRQoL domains and experienced higher rates of self-image issues, depression, and suicide. However, outcomes for patients with sarcoma were relatively comparable to those with other malignancies. Anxiety symptoms were more common in the diagnosis phase, while depressive symptoms were more common in the treatment phase. Patients who are older, female, and socially isolated often reported lower HRQoL. As a sarcoma-specific HRQoL instrument is not available, and all studies have used generic instruments, key issues may have been omitted. CONCLUSION: There are few studies reporting data for HRQoL, psychosocial issues, or unmet health needs in this population. A sarcoma-specific HRQoL instrument is needed to accurately describe outcomes in this population. There is a need for further qualitative research to conceptualise the HRQoL issues relevant to this population, against which to map existing HRQoL instruments and guide adaptation or creation of a new instrument.
OBJECTIVE: Health-related quality of life (HRQoL), psychosocial distress, and unmet health needs are important patient-reported outcomes (PROs) for patients with sarcoma treated with curative intent. Syntheses of data on these PROs in patients with sarcoma are limited. METHODS: A systematic review of peer-reviewed literature published between 2007 and 2017 was conducted using five databases, guided by the PRISMA and Cochrane reporting guidelines. RESULTS: Of 7240 articles identified, 31 were included in this review. Compared with healthy individuals, patients with sarcoma frequently scored lower in physical and psychological HRQoL domains and experienced higher rates of self-image issues, depression, and suicide. However, outcomes for patients with sarcoma were relatively comparable to those with other malignancies. Anxiety symptoms were more common in the diagnosis phase, while depressive symptoms were more common in the treatment phase. Patients who are older, female, and socially isolated often reported lower HRQoL. As a sarcoma-specific HRQoL instrument is not available, and all studies have used generic instruments, key issues may have been omitted. CONCLUSION: There are few studies reporting data for HRQoL, psychosocial issues, or unmet health needs in this population. A sarcoma-specific HRQoL instrument is needed to accurately describe outcomes in this population. There is a need for further qualitative research to conceptualise the HRQoL issues relevant to this population, against which to map existing HRQoL instruments and guide adaptation or creation of a new instrument.
Authors: Brian A Van Tine; Anders Krarup-Hansen; Lisa M Hess; Albiruni R Abdul Razak; Victoria Soldatenkova; Jennifer Wright; Se Hoon Park Journal: Rare Tumors Date: 2022-05-05
Authors: Elizabeth Donovan; Sarah R Martin; Laura C Seidman; Lonnie K Zeltzer; Tara M Cousineau; Laura A Payne; Marla Knoll; Margorie Weiman; Noah C Federman Journal: J Adolesc Young Adult Oncol Date: 2021-04-12 Impact factor: 2.223
Authors: Olga Husson; Winette T A van der Graaf; Dide den Hollander; Emma Lidington; Susanne Singer; Samantha C Sodergren; Samer Salah; Marco Fiore; Charlotte Benson; Ingrid M E Desar; Vivian W G Burgers Journal: Health Qual Life Outcomes Date: 2022-04-20 Impact factor: 3.077
Authors: Eugenie Younger; Robin L Jones; Ingrid M E Desar; Clare Peckitt; Winette T A van der Graaf; Olga Husson Journal: BMJ Open Date: 2020-06-01 Impact factor: 2.692
Authors: Dide den Hollander; Winette T A Van der Graaf; Marco Fiore; Bernd Kasper; Susanne Singer; Ingrid M E Desar; Olga Husson Journal: ESMO Open Date: 2020-10
Authors: Leopold Hentschel; Stephan Richter; Hans-Georg Kopp; Bernd Kasper; Annegret Kunitz; Viktor Grünwald; Torsten Kessler; Jens Marcus Chemnitz; Uwe Pelzer; Ulrich Schuler; Janet Freitag; Andrea Schilling; Beate Hornemann; Karin Arndt; Martin Bornhäuser; Markus Kajo Schuler Journal: BMJ Open Date: 2020-08-27 Impact factor: 2.692
Authors: Olga Husson; Winette Ta van der Graaf; Vicky Soomers; Ingrid Me Desar; Lonneke V van de Poll-Franse Journal: BMJ Open Date: 2020-10-26 Impact factor: 2.692
Authors: Matthias Büttner; Susanne Singer; Leopold Hentschel; Stephan Richter; Peter Hohenberger; Bernd Kasper; Dimosthenis Andreou; Daniel Pink; Kathy Taylor; Karin Arndt; Martin Bornhäuser; Jochen Schmitt; Markus K Schuler; Martin Eichler Journal: Support Care Cancer Date: 2021-07-11 Impact factor: 3.603